Blog | Veristat Insightful Perspectives

Contact Veristat Now


Request A Proposal

Contact Us

Beating Rare Cancers Requires Your Help - JOIN THE BATTLE TODAY!

January 11, 2019

As a scientifically oriented and impactful full-service clinical research organization (CRO) that is committed to partnering with pharmaceutical, biotechnology, and medical device firms to advance their therapies throughout the entire clinical development and regulatory submission process,  Veristat works each day with a focus on improving the lives of patients with rare cancers

Read More

Flexibility is the Key to Data Acquisition for Rare Disease Trials

March 27, 2018

Understanding Why Creative Solutions Are Necessary

With last month’s celebration of Rare Disease Month and specifically, Rare Disease Day, awareness of the research challenges faced by patients and pharma companies are especially high during this season.

Read More

Competing Risk Analysis in Clinical Trials | A Practical Example

October 3, 2017

In pharmaceutical clinical trials, considering competing risk analyses is highly important. Competing risks are events that may occur and prevent the evaluation of a specific primary endpoint, in turn biasing risk estimations or drug efficacy. 

Read More